{"type":"trials","record":{"id":34868,"source_id":"clinicaltrials-gov","external_id":"NCT04366388","title":"Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly","brief_summary":"The major purpose of this study is to establish the use of daily step counts as inexpensive, easy to measure marker for frailty and sarcopenia in an inpatient population of older adults.","overall_status":"Recruiting","phases":[],"study_type":"OBSERVATIONAL","sponsor":"University of British Columbia","enrollment":120,"countries":["Canada"],"start_date":"2022-06-01","completion_date":"2026-12-01","last_update_date":"2026-05-01","source_url":"https://clinicaltrials.gov/study/NCT04366388","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:20:20.087268+00:00","last_seen_at":"2026-09-25T06:10:25.747+00:00","metadata":{"sex":"ALL","acronym":null,"age_range":"65 Years","comparator":null,"organization":"University of British Columbia","interventions":["ActivPAL3 VT (PAL Technologies Ltd)."],"registry_source":"ClinicalTrials.gov","outcome_measures":["Total standing time — 2 weeks or shorter","Daily step counts — 2 weeks or shorter"],"design_description":null,"source_has_results":false},"controlled_terms":["Frail Elderly Syndrome","ActivPAL3 VT (PAL Technologies Ltd)."],"relevance_confidence":100,"source_quality_score":100,"freshness_score":100,"publication_state":"published","match_explanation":"Title contains controlled term: frailty.","quality_checked_at":"2026-09-25T06:10:37.875473+00:00","duplicate_cluster_key":"id:nct04366388","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2022-06-01 to 2026-12-01","comparator":null,"confidence":"structured-source","population":"ALL · 65 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:10:25.784Z","intervention":["ActivPAL3 VT (PAL Technologies Ltd)."],"participants":120,"study_design":"OBSERVATIONAL","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Total standing time — 2 weeks or shorter","Daily step counts — 2 weeks or shorter"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"frailty","is_published":true,"match_reasons":["Title contains controlled term: frailty.","Abstract contains controlled term: frailty.","Title supplies longevity context: frailty, frail.","Study type is explicitly identified as OBSERVATIONAL."],"matched_fields":["title","abstract","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Frailty","slug":"frailty"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/34868","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}